Literature DB >> 6154579

Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma.

E S Newlands, K D Bagshawe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154579     DOI: 10.1016/0014-2964(80)90359-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  6 in total

1.  Pharmacokinetics of VP16-213 given by different administration methods.

Authors:  M D'Incalci; P Farina; C Sessa; C Mangioni; V Conter; G Masera; M Rocchetti; M B Pisoni; E Piazza; M Beer; F Cavalli
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  The role of VP16-213 (etoposide; NSC-141540) in gestational choriocarcinoma.

Authors:  E S Newlands; K D Bagshawe
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Pharmacokinetics and toxicity of the epipodophyllotoxin derivative etoposide (VP 16-213) in patients with gestational choriocarcinoma and malignant teratoma.

Authors:  C J Brindley; P Antoniw; E S Newlands; K D Bagshawe
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02

5.  The effect of etoposide on human CFU-GM.

Authors:  R Bailey-Wood; C M Dallimore; T J Littlewood; D P Bentley
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

6.  Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.

Authors:  Toshiyuki Kanno; Hideo Matsui; Yoshika Akizawa; Hirokazu Usui; Makio Shozu
Journal:  J Gynecol Oncol       Date:  2018-11       Impact factor: 4.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.